INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium
Inovio, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that Thermo Fisher Scientific, the world leader in serving science, has signed a letter of intent to manufacture INOVIO’s DNA COVID-19 vaccine candidate INO-4800. Thermo Fisher Scientific will join existing partners […]
$6 Million Expansion for Gene Therapy Facility Completed at Alachua’s Progress Park
Local and state officials gathered in Alachua to commemorate a $6 million expansion at Progress Park. Representatives of Thermo Fisher Scientific Inc., a global science company involved with research and biotechnology product development, presented the company’s expanded gene therapy and viral vector services site. The day included tours of the 95,000-square-foot facility. University of Florida’s […]
The $1.7 Billion Deal: Sale of Brammer Bio Moves Region Toward Bio Hub
The sale of Greater Gainesville company Brammer Bio for $1.7 billion in April is a big step toward the region becoming a hub for biotechnology, business, and educational leaders. Thermo Fisher Scientific, which calls itself “the world leader in serving science” and employs 70,000 people, bought UF spinout company Brammer Bio – making it a […]
Thermo Fisher Scientific Completes Acquisition of Brammer Bio
Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for approximately $1.7 billion in cash. The completion of the transaction follows the receipt of all required regulatory approvals. Brammer Bio has nearly […]
Thermo Fisher to Acquire Brammer Bio in $1.7 Billion Gene-Therapy Deal
Thermo Fisher Scientific Inc. said it is buying Alachua-based Brammer Bio for $1.7 billion in a move that would expand the lab-equipment company’s presence in the rapidly growing field of gene therapy. Closely held Brammer Bio, owned by private-equity firm Ampersand Capital Partners, provides pharmaceutical companies developing gene therapies and gene-modified cell therapies with outsourced […]